Induction chemotherapy with/without radiation followed by surgery in stage III non-small-cell lung cancer

ONCOLOGY

Volumn 11, Issue 9 SUPPL., 1997, Pages 51-57

  Albain, Kathy S ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; FLUOROURACIL; MITOMYCIN C; VINBLASTINE SULFATE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG NON SMALL CELL CANCER; MEDICAL DECISION MAKING; MULTIMODALITY CANCER THERAPY; PREDICTION; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS;

EID: 0030844032     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Albain KS: Induction therapy followed by definitive local control for stage III non-small-cell lung cancer: A review, with a focus on recent trimodality trials. Chest 103:43S-50S, 1993.
2. Strauss GM, Langer MP, Elias AD, et al: Multimodalily treatment of stage IIIA non-small-cell lung carcinoma: A critical review of the literature and strategies for future research. J Clin Oncol 10:829-838, 1992
3. Rusch VW, Benfield JR: Neoadjuvant therapy for lung cancer: A note of caution. Ann Thorac Surg 55:820-821, 1993.
4. Edelman MJ, Gandara DR, Roach M III. et al: Multimodality therapy in stage III non-small-cell lung cancer. Ann Thorac Surg 61:1564-1572, 1996
5. Payne DG: Preoperative radiation therapy in non-small-cell cancer of the lung. Lung Cancer 7:47-56, 1991.
6. Lad T, Wagner H, Piantadosi S, for the Lung Cancer Study Group: Randomized phase II evaluation of pre-operative chemotherapy alone and radiotherapy alone in stage IIIA non-small-cell lung cancer (abstract). Proc Am Soc Clin Oncol 10:258, 1991.
7. Bitran JD, Golomb HM, Hoffman PC, et al: Protochemotherapy in non-small-cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary report. Cancer 57:44-53, 1986.
8. Skarin A, Jochelson M, Sheldon T, et al: Neoadjuvant chemotherapy in marginally resectable stage III MO non-small-cell lung cancer: Long-term follow-up in 41 patients. J Surg Oncol 40:266-274, 1989.
9. Elias AD, Skarin AT, Gonin R, et al: Neoadjuvant treatment of stage IIIA non-small-cell lung cancer. Am J Clin Oncol (CCT) 17:26-36
10. Eagan RT, Ruud C, Lee RE, et al for the Lung Cancer Study Group: Pilot study of induction therapy with cyclophosphamide, doxorubicin and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III MO non-small-cell lung cancer. Cancer Treat Rep 71:895-900, 1987.
11. Martini N, Kris MG, Flehinger BJ, et al: Preoperative chemotherapy for stage IIIA (N2) lung cancer: The Sloan-Kettering experience with 136 patients. Ann Thorac Surg 55:1365-1374, 1993.
12. Pisters KMW, Kris MG, Gralla RJ, et al: Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy. Implications for the design of future non-small-cell lung cancer combined modality trials. J Clin Oncol 11:1757-1762, 1993.
13. Burkes RL, Shepherd FA, Ginsberg RJ, et al: Induction chemotherapy with MVP in patients with stage IIIA (N2) unresectable non-small-cell lung cancer: The Toronto experience (abstract 1078). Proc Am Soc Clin Oncol 13:327, 1994.
14. Sugarbaker DJ, Herndon J, Kohman LJ, et al: Results of Cancer and Leukemia Group B Protocol 8935. A multi-institutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer J Thorac Cardiovasc Surg 109:473-485, 1995.
15. Albain KS, Rusch VW, Crowley JJ, et al: Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer. Mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13:1880-1892, 1995.
16. Weiden PL, Piantadosi S, for the Lung Cancer Study Group: Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: A phase II study of the LCSG. J Natl Cancer Inst 83:266-272, 1991.
17. Faber LP, Kittle CK, Warren WH, et al: Preoperative chemotherapy and irradiation for stage III non-small-cell lung cancer. Ann Thorac Surg 47:669-677, 1989.
18. Strauss GM, Herndon JE, Sherman DD, et al: Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung. Report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 10:1237-1244, 1992.
19. Bonomi P, Gale M, Faber LP, et al: Is clinical stage III non-small-cell lung cancer a homogeneous group?(abstract) Proc Am Soc Clin Oncol 11:292, 1992.
20. Curran WJ, Stafford PM: Lack of apparent difference in outcome between clinically staged IIIA and IIIB non-small-cell lung cancer treated with radiotherapy. 3 Clin Oncol 8:4409-4415, 1995.
21. Albain KS, Crowley JJ, Turrisi AT, et al: Concurrent cisplatin/etoposide plus radiotherapy for pathologic stage IIIB non-small-cell lung cancer: A Southwest Oncology Group phase II study (S9019) (abstract 1600). Proc Am Soc Clin Oncol 16:446a, 1997.
22. Pass HI, Pogrebniak H, Steinberg SM, et al: Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis. Ann Thorac Surg 53:992-1008, 1992.
23. Yoneda S, Hibino S, Gotoh I, et al: A comparative trial of induction chemoradiotherapy followed by surgery or immediate surgery for stage III NSCLC (abstract 1128). Proc Am Soc Clin Oncol 14:367, 1995.
24. Roth J, Fossella F, Komaki R, et al: A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage III non-small-cell lung cancer. J Natl Cancer Inst 86:673-680, 1994.
25. Rosell R, Gomez-Codina J, Camps C, et al: A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330:153-158, 1994.
26. Zeldin RA, Normandin D, Landtwing D, et al: Post-pneumonectomy pulmonary edema. J Thorac Cardiovasc Surg 87:359-365, 1984.
27. Mathru M, Blakeman B, Dries DJ: et al Permeability pulmonary edema following lung resection. Chest 98:1216-1218, 1990.
28. Roach M, Gandara DR, Yuo H-S, et al: Radiation pneumonitis following combined modality therapy for lung cancer: Analysis of prognostic factors. J Clin Oncol 13:2606-2612, 1995.
29. Fleck J, Camargo J, Godoy D, et al: Chemoradiation therapy vs chemotherapy alone as a neoadjuvant treatment for stage III non-small-cell lung cancer. Preliminary report of a phase III prospective randomized trial (abstract 1108). Proc Am Soc Clin Oncol 12:333, 1993.
30. McGinnis WL, Shaw EG, Jung S-H, et al: Results of a phase III prospective randomized trial comparing standard thoracic radiation therapy (TRT) to twice-daily TRT ± concomitant etoposide-cisplatin chemotherapy in patients with unresectable stage IIIA/B non-small-cell lung cancer (abstract 1079). Proc Am Soc Clin Oncol 14:355, 1995.
31. Furuse K, Fukuoka M, Takada Y, et al for the West Japan Lung Cancer Group: A randomized phase III study of concurrent vs sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small-cell lung cancer: Preliminary analysis (abstract 1649). Proc Am Soc Clin Oncol 16:459a, 1997.